3′UTR-mediated gene silencing of the mixed lineage leukemia (MLL) gene

PLoS ONE

Volumn 6, Issue 10, 2011, Pages

  Gomez Benito, Maria ^a,b   Loayza Puch, Fabricio ^a   Vrielink, Joachim Oude ^a   Odero, Maria D ^b   Agami, Reuven ^a,c  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

^b UNIVERSITY OF NAVARRA   (Spain)

^c Center for Biomedical Genetics   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; MICRORNA; RNA POLYMERASE II; MIXED LINEAGE LEUKEMIA PROTEIN; MLL PROTEIN, HUMAN;

3' UNTRANSLATED REGION; ACUTE GRANULOCYTIC LEUKEMIA; AF4 GENE; AF6 GENE; AF9 GENE; ARTICLE; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; GENE; GENE CONTROL; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE FUSION; GENE REARRANGEMENT; GENE REPRESSION; GENE SILENCING; GENE TRANSLOCATION; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; LEUKEMOGENESIS; MIXED LINEAGE LEUKEMIA GENE; ONCOGENE; TANDEM REPEAT; TRANSCRIPTION TERMINATION; FEMALE; GENETICS; LEUKEMIA; MALE; PATHOLOGY; TUMOR CELL LINE;

3' UNTRANSLATED REGIONS; CELL LINE, TUMOR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE FUSION; GENE SILENCING; HUMANS; LEUKEMIA; MALE; MYELOID-LYMPHOID LEUKEMIA PROTEIN; TRANSLOCATION, GENETIC;

EID: 80053577330     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0025449     Document Type: Article

References (24)

1. Liedtke M, Cleary ML, (2009) Therapeutic targeting of MLL. Blood 113: 6061-6068.
2. Burmeister T, (2010) MLL: exploring the methylome. Blood 115: 4627-4628.
3. Tkachuk DC, Kohler S, Cleary ML, (1992) Involvement of a homolog of Drosophila trithorax by 11q23 chromosomal translocations in acute leukemias. Cell 71: 691-700.
4. Ayton PM, Cleary ML, (2001) Molecular mechanisms of leukemogenesis mediated by MLL fusion proteins. Oncogene 20: 5695-5707.
5. Popovic R, Zeleznik-Le NJ, (2005) MLL: how complex does it get? J Cell Biochem 95: 234-242.
6. Thirman MJ, Gill HJ, Burnett RC, Mbangkollo D, McCabe NR, et al. (1993) Rearrangement of the MLL gene in acute lymphoblastic and acute myeloid leukemias with 11q23 chromosomal translocations. N Engl J Med 329: 909-914.
7. Keefe JG, Sukov WR, Knudson RA, Nguyen LP, Williamson C, et al. (2010) Development of five dual-color, double-fusion fluorescence in situ hybridization assays for the detection of common MLL translocation partners. J Mol Diagn 12: 441-452.
8. Krivtsov AV, Armstrong SA, (2007) MLL translocations, histone modifications and leukaemia stem-cell development. Nat Rev Cancer 7: 823-833.
9. Lavau C, Szilvassy SJ, Slany R, Cleary ML, (1997) Immortalization and leukemic transformation of a myelomonocytic precursor by retrovirally transduced HRX-ENL. EMBO J 16: 4226-4237.
10. Martin ME, Milne TA, Bloyer S, Galoian K, Shen W, et al. (2003) Dimerization of MLL fusion proteins immortalizes hematopoietic cells. Cancer Cell 4: 197-207.
11. Armstrong SA, Staunton JE, Silverman LB, Pieters R, den Boer ML, et al. (2002) MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia. Nat Genet 30: 41-47.
12. Mayr C, Bartel DP, (2009) Widespread shortening of 3′UTRs by alternative cleavage and polyadenylation activates oncogenes in cancer cells. Cell 138: 673-684.
13. Fabian MR, Sonenberg N, Filipowicz W, (2010) Regulation of mRNA translation and stability by microRNAs. Annu Rev Biochem 79: 351-379.
14. le Sage C, Nagel R, Egan DA, Schrier M, Mesman E, et al. (2007) Regulation of the p27(Kip1) tumor suppressor by miR-221 and miR-222 promotes cancer cell proliferation. EMBO J 26: 3699-3708.
15. Kedde M, Strasser MJ, Boldajipour B, Oude Vrielink JA, Slanchev K, et al. (2007) RNA-binding protein Dnd1 inhibits microRNA access to target mRNA. Cell 131: 1273-1286.
16. Mayr C, Hemann MT, Bartel DP, (2007) Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation. Science 315: 1576-1579.
17. Bagga S, Bracht J, Hunter S, Massirer K, Holtz J, et al. (2005) Regulation by let-7 and lin-4 miRNAs results in target mRNA degradation. Cell 122: 553-563.
18. Lim LP, Lau NC, Garrett-Engele P, Grimson A, Schelter JM, et al. (2005) Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 433: 769-773.
19. Cummins JM, He Y, Leary RJ, Pagliarini R, Diaz LA Jr, et al. (2006) The colorectal microRNAome. Proc Natl Acad Sci U S A 103: 3687-3692.
20. Ebert MS, Neilson JR, Sharp PA, (2007) MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells. Nat Methods 4: 721-726.
21. Kimura H, Sugaya K, Cook PR, (2002) The transcription cycle of RNA polymerase II in living cells. J Cell Biol 159: 777-782.
22. Dolken L, Ruzsics Z, Radle B, Friedel CC, Zimmer R, et al. (2008) High-resolution gene expression profiling for simultaneous kinetic parameter analysis of RNA synthesis and decay. RNA 14: 1959-1972.
23. Cierpicki T, Risner LE, Grembecka J, Lukasik SM, Popovic R, et al. Structure of the MLL CXXC domain-DNA complex and its functional role in MLL-AF9 leukemia. Nat Struct Mol Biol 17: 62-68.
24. Lahortiga I, Vazquez I, Agirre X, Larrayoz MJ, Vizmanos JL, et al. (2004) Molecular heterogeneity in AML/MDS patients with 3q21q26 rearrangements. Genes, chromosomes & cancer 40: 179-189.